In the News

Intensive therapy associated with decreases in certain cardiovascular events, new ACCORD analysis finds

Despite the ACCORD study finding an increased risk of death from cardiovascular causes with intensive glucose-lowering therapy, rates of myocardial infarction, coronary revascularization, and unstable angina were lower in patients on an intensive regimen, a new analysis of the trial data found.

Risk for poor outcomes appears higher in diabetic patients with lacunar stroke

Patients with diabetes who have lacunar stroke are at higher risk for death and recurrent stroke than patients without diabetes, according to a recent study.

MKSAP quiz: Treatment plan for obesity and diabetes

This month's quiz asks readers to evaluate a 42-year-old-man with type 2 diabetes, hypertension, and hyperlipidemia for obesity treatment.

Nurse-managed protocols associated with modest improvement in control of chronic conditions, analysis finds

Medication titration by nurses according to protocols was associated with a modest improvement in control of chronic diseases in outpatient practice, a recent review and meta-analysis found.

Empagliflozin approved to treat type 2 diabetes

Empagliflozin (Jardiance), a sodium glucose co-transporter 2 inhibitor, was recently approved to treat type 2 diabetes in addition to diet and exercise, the FDA announced last week.

Spotlight on office visits for diabetes

New data on how often diabetes patients visit their physicians were provided by 2 recent analyses.